Xylem said on February 25, 2026 its Board of Directors approved adoption of a new share repurchase program. The program has no expiration date.

1. 01

   Xylem said on February 25, 2026 its Board of Directors approved adoption of a new share repurchase program. The program has no expiration date.

2. 02

   The company said it is authorized to repurchase common stock with a par value of $0.01 for up to $1.5 billion under the new program.

3. 03

   Xylem said repurchases under the new program may be made through open market purchases or otherwise, in compliance with applicable laws and regulations, upon such terms and conditions and at such times and in such amounts not in excess of the authorized aggregate amount.

4. 04

   The company said the new program does not obligate it to acquire any particular amount of common stock and it may be suspended at any time in the company's discretion.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.